Adage Capital Partners’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Adage Capital Partners’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,509,500	Closed	-$12.2M	–	1115
2021 Q3	$12.2M	Hold	1,509,500	–	–	0.02%	636
2021 Q2	$14.8M	Hold	1,509,500	–	–	0.03%	573
2021 Q1	$13.3M	Hold	1,509,500	–	–	0.03%	591
2020 Q4	$15.4M	Hold	1,509,500	–	–	0.03%	488
2020 Q3	$13.6M	Hold	1,509,500	–	–	0.03%	465
2020 Q2	$10.8M	Buy	1,509,500 +200,000	+15%	+$2.12M	0.03%	511
2020 Q1	$12.4M	Buy	1,309,500 +9,500	+0.7%	+$122K	0.04%	420
2019 Q4	$17.1M	Buy	+1,300,000	New	+$15.9M	0.04%	415

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners's GRTX Position: Q4 2021 in Review

Adage Capital Partners sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2021, closing a stake of 1,509,500 shares — an estimated $12.2M sold.

Adage Capital Partners first reported a position in GRTX in Q4 2019 and held it in 8 quarters. The position peaked at $17.1M in Q4 2019. 44 funds tracked by Wall St. Rank hold GRTX as of Q4 2021.

Adage Capital Partners reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Adage Capital Partners sold 1,509,500 Galera Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $12.2M.
Adage Capital Partners first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
Adage Capital Partners's Galera Therapeutics, Inc. Common Stock position peaked at $17.1M in Q4 2019.
44 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Adage Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.